 Connection
Daniel Matlock to Patient Reported Outcome Measures
This is a "connection" page, showing publications Daniel Matlock has written about Patient Reported Outcome Measures.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.889 |
|
|
|
-
Pytell JD, Pales D, Simon C, Beaudoin J, Osman AMY, Svoboda E, Christine PJ, Matlock D, Schwartz R, Binswanger IA. Systematic review of patient-reported outcome measures for opioid use disorder recovery. Addiction. 2026 Mar; 121(3):488-498.
Score: 0.169
-
Canty GA, Helmkamp L, Leslie SE, Vemuru S, Adams M, Higgins MG, Davis RA, Scherer LD, Baurle E, Matlock DD, Lee C, Tevis S. Evaluation of visual displays to share expected quality of life changes with patients with breast cancer. Surgery. 2025 Dec; 188:109770.
Score: 0.168
-
Higgins MG, Vemuru S, Helmkamp L, Adams M, Colborn K, Parris H, Huynh V, Christian N, Ahrendt G, Lee C, Kim S, Matlock D, Cumbler E, Tevis S. Access to results of patient reported outcome surveys did not improve longitudinal patient reported outcomes in breast cancer patients in a randomized controlled trial. Am J Surg. 2025 Jan; 239:116054.
Score: 0.158
-
Vemuru S, Helmkamp L, Adams M, Colborn K, Parris H, Huynh V, Higgins M, Christian N, Ahrendt G, Baurle E, Lee C, Kim S, Matlock D, Cumbler E, Tevis S. Longitudinal Trends in Patient-Reported Outcomes in the First Year After Lumpectomy Versus Mastectomy. Ann Surg Oncol. 2024 Oct; 31(11):7597-7606.
Score: 0.155
-
Vemuru S, Smith S, Colborn K, Huynh V, Leonard L, Bonnell L, Scherer L, Matlock D, Lee C, Kim S, Tevis S. Access to Results of Patient Reported Outcome Surveys Does Not Improve Survey Response Rates. J Surg Res. 2023 03; 283:945-952.
Score: 0.138
-
Mott NM, Huynh V, Vemuru S, Parris HJ, Colborn K, Ahrendt G, Christian N, Kim S, Matlock DD, Cumbler E, Tevis SEA. Barriers and facilitators to measuring patient reported outcomes in an academic breast cancer clinic: An application of the RE-AIM framework. Am J Surg. 2024 02; 228:180-184.
Score: 0.036
-
Goyal P, Safford MM, Hilmer SN, Steinman MA, Matlock DD, Maurer MS, Lachs MS, Kronish IM. N-of-1 trials to facilitate evidence-based deprescribing: Rationale and case study. Br J Clin Pharmacol. 2022 10; 88(10):4460-4473.
Score: 0.034
-
Huynh V, Colborn K, Smith S, Bonnell LN, Ahrendt G, Christian N, Kim S, Matlock DD, Lee C, Tevis SE. Early Trajectories of Patient Reported Outcomes in Breast Cancer Patients Undergoing Lumpectomy Versus Mastectomy. Ann Surg Oncol. 2021 Oct; 28(10):5677-5685.
Score: 0.031
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|